Grants for Researchers

National Institutes of Health · Amount varies

This NIH/NINDS award (R61/R33) funds pharmacology and in vivo efficacy studies to advance candidate therapeutics for neurological and neuromuscular disorders toward further translational development. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, tribal governments, foreign organizations, and U.S. territories; it targets research organizations rather than individuals. No award amount is specified. The work is narrowly defined preclinical drug-development research.

National Institutes of Health · Up to $750K

This NIH/NINDS award (R61/R33) funds development of in vitro and ex vivo assays and screening to identify candidate therapeutics for neurological and neuromuscular disorders; no clinical trial is allowed. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, and tribal governments; it targets research organizations, not individuals. Awards run up to about $750,000. The early-stage drug-discovery focus makes the scope narrow.

National Institutes of Health · Up to $750K

This NIH/NINDS award (R61/R33) funds development and validation of animal models and tissue systems that mimic neurological and neuromuscular disorders to support future neurotherapeutic discovery; no clinical trial is allowed. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, and tribal governments; it targets research organizations, not individuals. Awards run up to about $750,000. The model-development focus makes the scope narrow.

National Institutes of Health · Amount varies

This NIH/NCI R34 planning grant funds the design and preparation of cancer prevention and control clinical trials, covering screening, early detection, supportive care, and survivorship. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, tribal governments, foreign organizations, and U.S. territories; it targets research organizations, not individuals. No award amount is specified. It funds trial-planning activities rather than the trials themselves.

National Institutes of Health · Amount varies

This NIH/NCI U34 planning grant funds the design and preparation of cancer prevention and control clinical trials, including studies on screening, early detection, and survivorship. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, tribal governments, foreign organizations, and U.S. territories; it is aimed at research organizations, not individuals. No award amount is specified. It funds trial-planning work rather than the trials themselves, so review the scope carefully.

National Institutes of Health · Amount varies

This NIH/NIMH U01 funds individual research projects to discover and develop new drugs and neurostimulation approaches for mental disorders, substance use disorders, and alcohol use disorder. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, and tribal governments; foreign organizations are not eligible, and it targets research organizations rather than individuals. No award amount is specified. The drug/device discovery focus makes the scope narrow.

National Institutes of Health · Amount varies

This NIH/NIMH U19 funds multi-project programs to discover and develop new drugs and neurostimulation approaches for mental disorders, substance use disorders, and alcohol use disorder. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, and tribal governments; foreign organizations are not eligible, and it targets research organizations, not individuals. No award amount is specified. It supports large multidisciplinary programs, so the scope is narrow.

National Institutes of Health · Up to $375K

This NIH R15 (REAP) award funds small-scale research and student research experiences at health-professional and graduate schools that receive limited NIH funding, with a minimal-risk clinical trial required. Eligibility is restricted to degree-granting institutions that have received no more than $6 million per year of NIH support in 4 of the last 7 years; foreign organizations are not eligible. Awards reach up to about $375,000. The NIH-funding cap and institution-type limits make eligibility narrow, so verify your institution qualifies.

National Institutes of Health · Amount varies

This NIH/NINDS U01 is a limited competition open only to applicants holding existing NINDS-supported clinical trial cooperative agreement awards that need more time and resources to finish. Because it is restricted to current grantees, new applicants are not eligible; foreign organizations are also excluded. No award amount is specified. This opportunity does not apply to organizations that do not already hold the relevant NINDS award.

National Institutes of Health · Amount varies

This NIH/NIDDK R01 funds HIV/AIDS research aligned with NIDDK's mission and the NIH Office of AIDS Research priorities. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, and tribal governments; it targets research organizations rather than individuals. No award amount is specified. Projects must fit the stated HIV/AIDS research priorities, so the scope is specific.

National Institutes of Health · Up to $1.5M

This NIH/NIA U01 funds preclinical and early (Phase I) clinical development of new drug candidates that aim to prevent, slow, or treat Alzheimer's disease. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, and tribal governments; it targets research organizations, not individuals. Awards run up to about $1.5 million. Basic mechanism studies, repurposed drugs, and stand-alone clinical trials are out of scope, so the research focus is narrow.

National Institutes of Health · Amount varies

This NIH BRAIN Initiative R01 funds development of computational theories, models, and methods for analyzing complex brain-circuit data, to be shared with the research community. Eligible applicants are research organizations, including faith- or community-based organizations, tribal governments, foreign organizations, and U.S. territories; it targets institutions rather than individuals. No award amount is specified. The work is narrowly scoped to neural-circuit tool building, so confirm fit before applying.

National Institutes of Health · Up to $350K

This NIH/NIDA award funds research education programs that train clinicians and clinical researchers in substance use and substance use disorder research. Eligible applicants are research and education institutions, including HBCUs, Hispanic-serving and tribal-serving institutions, faith- or community-based organizations, and tribal governments; it is aimed at organizations, not individuals. Awards run up to about $350,000. Note the program supports research education only, not non-research clinical training, so review the stated scope carefully.

National Institutes of Health · Amount varies

This NIH/NINDS K22 career-transition award helps NINDS intramural neurologist- and neurosurgeon-scientists move to independent academic faculty positions, with a clinical trial required. It is applied for through a research or education institution but is restricted to NINDS intramural clinician-scientists, making eligibility very narrow; foreign organizations and components are not eligible. No award amount is specified. Most outside applicants will not qualify for this opportunity.

National Institutes of Health · Amount varies

This NIH/NINDS K22 career-transition award helps NINDS intramural neurologist- and neurosurgeon-scientists move to independent academic faculty positions; no clinical trial is allowed. It is applied for through a research or education institution but is restricted to NINDS intramural clinician-scientists, so eligibility is very narrow; foreign organizations and components are not eligible. No award amount is specified. Most outside applicants will not qualify for this opportunity.

National Institutes of Health · Amount varies

This NIH/NIA K07 career award supports established investigators who lead efforts to build aging and Alzheimer's/dementia research capacity, mentorship, and infrastructure at their academic institution. It is applied for through a research or education institution but effectively targets individual senior investigators; foreign organizations are not eligible, and it does not allow leading an independent clinical trial. No award amount is specified. Applicants should confirm they meet the leadership and career-stage criteria, which are specific.

National Institutes of Health · Amount varies

This NIH/NCI R01 funds advanced preclinical research translating nanotechnology-based cancer diagnostics and therapeutics toward later NCI translational programs; no clinical trial is allowed. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, and tribal governments; it targets research organizations, not individuals. Foreign organizations are not eligible. No award amount is specified, and the nanomedicine focus makes the scope narrow.

National Institutes of Health · Amount varies

This NIH (R01) opportunity funds research developing novel screening approaches or therapies for fatal or disabling conditions identified through newborn screening, including high-priority genetic conditions. It is intended for research and academic institutions rather than individuals or general nonprofits/small businesses. No specific award amount is stated.

National Institutes of Health · Up to $200K

This NIH (R21) opportunity funds research developing novel screening approaches or therapies for fatal or disabling conditions identified through newborn screening, including high-priority genetic conditions. It is intended for research and academic institutions rather than individuals or general nonprofits/small businesses. The maximum award is about $200,000.

National Institutes of Health · Amount varies

This NIH (R21) opportunity funds basic, mechanistic research into the biological and genetic causes of cancer health disparities, including new methods, models, and secondary data analyses. It is intended for research and academic institutions rather than individuals or general nonprofits/small businesses. No specific award amount is stated.